Skip to main content

Advertisement

Peer Review reports

From: Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

Original Submission
29 Nov 2016 Submitted Original manuscript
30 Jan 2017 Reviewed Reviewer Report - Johannes Nossent
3 Mar 2017 Reviewed Reviewer Report - William Rigby
26 Mar 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 2
26 Mar 2017 Submitted Manuscript version 2
30 Mar 2017 Reviewed Reviewer Report - Johannes Nossent
24 Apr 2017 Reviewed Reviewer Report - William Rigby
21 May 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 3
21 May 2017 Submitted Manuscript version 3
25 May 2017 Reviewed Reviewer Report - Johannes Nossent
17 Jun 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 4
17 Jun 2017 Submitted Manuscript version 4
Publishing
13 Jul 2017 Editorially accepted
19 Jul 2017 Article published 10.1186/s12891-017-1673-3

You can find further information about peer review here.

Back to article page